Digirad Financial Ratios

Digirad Corporation -- USA Stock  

USD 1.38  0.02  1.43%

We found thirty-seven available fundamental indicators for Digirad Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Digirad fundamentals including its Shares Outstanding, Price to Sales, Cash per Share, as well as the relationship between Number of Shares Shorted and EBITDA . Given that Digirad is a hitting penny stock territory we advise to closely look at its Price to Earning.

Digirad Valuation Over Time

Enterprise Value

Digirad Company Summary

Digirad competes with Edwards Lifesciences, EndoChoice Holdings, DarioHealth Corp, Viveve Medical, and DEXCOM. Digirad Corporation provides healthcare solutions in the United States. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia. Digirad operates under Medical Devices classification in USA and traded on NASDAQ General Markets. It employs 515 people.

Digirad Current Ratio vs Gross Profit

Digirad Corporation is rated # 5 in current ratio category among related companies. It is rated # 2 in gross profit category among related companies fabricating about  18,807,947  of Gross Profit per Current Ratio.

Digirad Market Fundamentals

 Change(%) 1.43%

Distress Rating

Digirad Financial Distress Probability
< 54% 

Chance of Financial Distress

Digirad Corporation has more than 54 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Digirad Thematic Clasifications

Active Themes That Utilize Digirad
Medical Equipment IdeaMedical EquipmentView


Digirad Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth


Compare Digirad To Peers
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Additionally see Investing Opportunities. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.